Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
FDA Clears Pharmaxis Cancer Drug to Progress to Phase 2 Study in Liver Cancer 2021-11-09 19:00
Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial 2021-10-05 18:00
Pharmaxis Treatment to Prevent Wound and Burns Scars Clears Phase 1 Trial 2021-08-31 18:00
Pharmaxis Cancer Drug Decreases Tumour Burden in Pre Clinical Liver Cancer Model 2021-08-05 18:00
Boehringer Ingelheim initiates Phase IIa study of compound acquired from Pharmaxis in debilitating liver disease NASH 2017-08-25 08:39
Boehringer Ingelheim Acquires Pharmaxis' Phase 1 Anti-inflammatory Drug Candidate 2015-05-18 11:19
1